While a few multinational pharmaceutical companies have confirmed their foreign executives would be leaving the position, the Korean Research-based Pharmaceutical Industry Association’s (KRPIA) board of director (BOD) is also expected to undergo some changes as well.

The two foreign executives bidding farewell are MSD Korea’s CEO Avi BenShoshan and GSK Korea’s Vice President and General Manager Julien Samson. Currently, CEO Avi BenShoshan is the Chairman of KRPIA and VP and General Manager Julien Samson is a Vice-chair.

The focus of the industry lies on the possibility of expanding the Korean executives among the KRPIA BODs. Considering Chairman Avi BenShoshan’s term is to last unt